Sanofi SA vs Warner Music Group Corp — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Warner Music Group Corp trades at $28.2 (market cap $14.64B). The key difference: Sanofi SA is far larger — about 7.2× Warner Music Group Corp's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| SNY | WMG | |
|---|---|---|
Market Cap | $104.83B | $14.64B |
Sector | Health | Media |
52-Week High | $52.34 | $34.72 |
52-Week Low | $41.33 | $23.65 |
Enterprise Value | $121.32B | $18.84B |
Dividend Yield | 5.5% | 2.71% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →